MedPath

Clinical trial on efficacy and safety of long-term Rebamipide therapy for successful eradication of Helicobacter pylori.

Not Applicable
Conditions
Patients who successful eradication therapy of Helicobacter pylori.
Registration Number
JPRN-UMIN000002369
Lead Sponsor
Department of Internal Medicine, division of Gastroenterology Kawasaki Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects with malignancy 2) Drug allergy 3) Severe complication 4) take non-steroidal inflammatory drugs 5) H. pylori eradication failure after first and second-line therapy. 6) Cases with unsuitable recognition by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath